HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutrient Research Needs Non Evidence-Based Options – Researchers

This article was originally published in The Tan Sheet

Executive Summary

The scientific community needs to explore new approaches to nutrition research outside the evidence-based medicine paradigm in order to advance public policy recommendations for optimal nutrient intakes, according to authors of an upcoming text on nutrient research

You may also be interested in...



FDA Health Claims Draft Guidance Should Value Totality Of Evidence – CRN

FDA's apparent contention that results from randomized controlled trials invalidate conflicting information from observational studies on the effects of nutrients reflects "an intrinsic bias" within the agency or "a lack of fundamental understanding of research methods," according to the Council for Responsible Nutrition

Supplement Firms Should Value RCTs, But Also Improve Other Research – CRN

Supplement firms must adapt clinical research methods to accommodate the industry's unique challenges and gain acceptance from mainstream medicine, Council for Responsible Nutrition President and CEO Steve Mister said during the trade group's Day of Science workshop May 3

More Multivitamin Research Needed To Show Disease Prevention – NIH Panel

Members of an independent NIH panel evaluating the safety and effectiveness of multivitamin/minerals (MVMs) hope that a draft report containing their recommendations will spur action on research efforts for the supplement category

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel